Manufacture of pharmaceutical preparations
PALLA PHARMA NORWAY HOLDING AS
Operating profit
NOK −14,000
Equity
NOK 91.0m
Incorporated
2017
Share capital
NOK 2.2m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 14k | |
| Operating profit (EBIT) | −14k | |
| Net financial items | −44.9m | |
| Profit for the year | −44.9m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 102.5m | |
| of which current assets | 6.4m | |
| Equity | 91.0m | |
| Total liabilities | 11.5m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.